clvs – Page 2 – Scalper1

Clovis Technology Gets Big Boost From Goldman Upgrade

Clovis Technology (CLVS) stock rose Monday after Goldman Sachs upgraded its rating and sharply raised its stock price target on the developer of anti-cancer treatments. Goldman upgraded Clovis to a buy from neutral and increased the price target to 117 from 68. Clovis stock was up nearly 13% in late-afternoon trading on the stock market today, at a 13-month high near 88. Clovis stock is up more than 55% this year The biopharmaceutical company is

Clovis Cancer ‘Breakthrough,’ Oculus Flop Top Biotech News Late

Clovis Oncology (CLVS) shares rose in after-hours trading on ovarian cancer news, one of several notable biotech announcements late Monday. Clovis announced that the Food and Drug Administration has given its rucaparib agent as a “breakthrough therapy” as sole treatment for advanced ovarian cancer patients. That means the FDA will give it an accelerated review. Clovis could seek FDA approval in 2016. Shares rose 7.4% to 73.74 in late trading on